机译:甲氨蝶呤在肥胖2型糖尿病患者中的功效:瘦素耐受性的细胞和分子途径
Hytin-Seuk Moon/ Giuseppe Matarese,2 Aoife M. Brennan,1 John P. Chamberland,1 Xiaowen Liu,1 Christina G. Fiorenza,1 Geetha H. Mylvaganam,1 Luisa Abanni,2 Fortunata Carbone,2 Catherine J. Williams,1 Alex M. De Paoli,3 Benjamin E. Schneider,4 and Christos S. Mantzoros1'5Prom the 'Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, the 2Laboratorio di Immunologia, Istituto di Endocrinologia e Oncologia Sperimentale, Conisglio Nazionale delle Ricerche c/o Dipartimento di Biologia e Patologia Cellulare e Molecolare, Universit? di Napoli Federico II, Napoli, Italy, 3Amgen, Inc., Thousand Oaks, California, the 4Division of Minimally Invasive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, and the ^Section of Endocrinology, Boston VA Healthcare System, Harvard Medical School, Boston, Massachusetts.Corresponding author: Christos S. Mantzoros, cmantzor@bidmc.liarvard.edu.Received 28 December 2010 and accepted 16 March 2011.DOI: 10.2337/dbl0-l?91. Clinical trial reg. no. NCT01275053, clinicaltrials.gov.This article contains Supplementary Data online at http://diabetes, diabetesjournals.org/lookup/suppl/doi:10.2337/dbl0-1791/VDCl.The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health.© 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecortunons.org/license&'by -nc-nd/3.0/ for details.,;
机译:甲氨蝶呤在肥胖2型糖尿病患者中的功效:瘦素耐受性的细胞和分子途径
机译:患有1型糖尿病患者的Metreleptin治疗的疗效和安全性:试验研究
机译:肥胖或脂肪营养不良患者与甲氨蝶呤治疗相关的免疫原性
机译:2型糖尿病患者ACE基因I / D多态性与肥胖
机译:在一个孤立的加拿大原住民社区中评估适应性及其与2型糖尿病,糖耐量受损和肥胖的关系。
机译:甲氨蝶呤在肥胖2型糖尿病患者中的功效:瘦素耐受性的细胞和分子途径
机译:甲氨蝶呤在肥胖2型糖尿病患者中的功效:瘦素耐受性的细胞和分子途径